Launched Vestrant (Fulvestrant For Injection)

Launched Fulvestrant For Injection in 2019 by the brand name Vestrant 250mg/5ml.

Approved indications of Vestrant

• Treatment of HR- positive advanced breast cancer in postmenopausal women with disease progression following endocrine therapy